NIAID investigators and collaborators at @ImmunoScape and @JHUcovidplasma recently published a study in @jclinicalinvest characterizing #Tcell responses in people who recover from #SARSCoV2 infection.…
T cells are a type of white blood cell part of the immune system & may allow for long-term protection against #SARSCoV2. Learning more about natural infection can help guide development of improved treatments and vaccines.
The researchers found that the majority of CD8+ T cells targeted internal and non-structural sites on viral proteins (epitopes), indicating possible targets for next-generation vaccines.
The team built on this research by examining SARS-CoV-2 variants #B117 #B1351 #B11248 for overlap with the identified epitopes from the prior study & found that virtually all CD8+ T-cell responses should recognize the variants, which should partly mediate protection from disease.
The new findings have yet to be peer-reviewed but are available online as a pre-print…

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with NIAID News

NIAID News Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!